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In this study we tried to focus on proliferative activity and seems to be accompanied by a loss of cell-cell adhesion molecules which enables the cells to escape from their tissue expression of the epidermal growth factor (EGF) and its organization and migrate into the neighbouring organs as a receptor (EGF-R) involved in endometrial proliferation precondition for the persistence of ectopic endometriotic (Haining et al., 1991) . We focused on EGF and EGF-R among lesions. Growth of endometriotic lesions, however, seems to other growth factors since it has been shown that both are be regulated, since uncontrolled proliferation of the ectopic localized in the epithelial as well as in the stromal compartment tissues is rarely observed in endometriosis. To test the hypoof human endometrium (Smith, 1994) . In contrast to insulinthesis that this disease has a more invasive than proliferative like growth factor-I receptor (IGF-I-R), EGF-R shows an character, we investigated markers for invasion properties as increase in the endometrium during the proliferative well as proliferative activity. phase (Konopka et al., 1998) and in oestrogen-exposed endometria (McBean et al., 1997) . In addition, EGF is able to
Materials and methods
stimulate proliferative activity in human stromal cells in vitro (Chegini et al., 1992) . On the other hand, we investigated the Patients cell adhesion molecule E-cadherin and its associated proteins, Endometrial biopsies and endometriotic tissues were obtained from α-and β-catenin, in endometriosis to gain information on the patients in the proliferative phase of the menstrual cycle who were invasive character of this disease. To discriminate between undergoing laparoscopy or being hysterectomized at the Department of Gynaecology of the University of Essen, Germany. Endometrial dedifferentiation processes which occur in the endometriotic tissues were recruited from women who were undergoing hysterlesions due to the influence of an ectopic environment and those ectomy because of leiomyomata or hysteroscopy for infertility primary events which cause the pathogenesis, we compared reasons. These endometrial tissues were compared with biopsies taken endometriotic lesions with endometria from patients with and from women diagnosed for endometriosis by hysteroscopy and without endometriosis from the same cyclic phase.
laparoscopy. The peritoneal endometriotic lesions were taken from Dedifferentiation of the uterine epithelium at ectopic sites the vesicouterine pouch, the rectouterine pouch and the ligamenta sacro-uterina of the uterus.
The women were aged 21-44 years. Blood of all patients was staining, the endometria from 36 patients without endometriosis and 79 endometria and/or endometriotic lesions of affected patients were E-cadherin Dianova, Hamburg, Germany 7 α-catenin Santa Cruz Biotechnology, Heidelberg, Germany 2 investigated. However, due to methodical problems, the complete set β-catenin Sigma-Aldrich Chemie, Deisenhofen, Germany 30 of marker genes could not be analysed from every patient. The precise EGF Dianova, Hamburg, Germany 8 data are given in the figure legends.
EGF-R Dako Diagnostik GmbH, Hamburg, Germany 30 Ki67
Medac GmbH, Hamburg, Germany 0.5
Immunohistochemistry
Sources of the different antibodies and concentrations used are EGF ϭ epidermal growth factor; EGF-R ϭ epidermal growth factor receptor.
summarized in Table I . For cryostat sections, the biopsies were immediately frozen in liquid nitrogen and kept at -80°C. For staining The significance of the differences in proliferative activity of glandular epithelium in eutopic and ectopic endometria was deterof antigens to EGF, EGF-R, E-cadherin-, α-catenin-, and β-catenin, 7 µm thick cryostat sections were processed routinely. Briefly, mined by a generalized linear model assuming a binomial distribution with overdispersion. Overdispersion (McCullagh and Nelder, 1989 ) sections were fixed for 10 min in 96% ethanol and after rinsing with phosphate-buffered saline (PBS) covered with 1% bovine serum between replicates of binary distribution occurs when the variation between the observation is higher than could be explained by a albumin solution (BSA; Sigma, Germany) to block non-specific binding sites. Incubation with the primary antibody for 1 h was sample of independent binomial variates. Modelling overdispersion allows a more realistic estimation of P values and confidence intervals followed by the appropriate secondary fluorescein isothiocyanate (FITC)-conjugated antibody for 45 min. Sections were covered with in the context of generalized linear models. Vectashield (Vector Laboratories, Peterbourgh, UK) and analysed using an Axiophot immunofluorescence microscope (Zeiss, Oberkochen, Germany). The intensity of the staining was analysed twice on different
Results

days. The intensity of immunostaining was semiquantitatively
Immunohistochemistry was performed in eutopic as well as evaluated as: -ϭ no staining; ϩ ϭ weak staining; ϩϩ ϭ moderate ectopic endometrial tissues during the early to late proliferative staining; and ϩϩϩ ϭ strong staining.
phase on days 6-14 of the menstrual cycle.
Ki67 antigen expression was determined using a streptavidinbiotin peroxidase complex immunohistochemical technique (Dako LSAB ϩ Kit Peroxidase; Dako, Hamburg, Germany) on cryostat Proliferation sections as described above. After incubation with the primary endometriotic biopsies no Ki67 antigen was detectable ( Figure  1c ). In the remaining samples only some glandular epithelial (data not shown), whereas no staining for Ki67 was detected nearly identical. The intensity of the immunoreaction was moderate (Figure 3b ). The EGF was localized mainly close to the apical portion and showed a weak expression in the basal region and the lateral membranes of the glandular epithelium (Figure 2a,b) .
In contrast to eutopic endometria, endometriotic biopsies revealed only weak EGF immunostaining in the same distribution pattern. In 34% of the samples, EGF was undetectable (Figures 2c, 3b) .
In endometria of women with and without endometriosis the immunoreaction against EGF-R was similar (Figure 3c) . Most of the samples of these eutopic endometria showed a moderate immunofluorescence staining (Figure 3c ). EGF-R was localized at the basal, and to some extent at the lateral, portion of the epithelial cell membranes (Figure 2d,e) .
In contrast to the eutopic endometria, endometriotic biopsies (48%) revealed a low concentration of EGF-R protein ( Figure  2f ) and even in 32% of the lesions EGF-R expression was not detectable (Figure 3c ). Comparison of EGF with its receptor revealed approximately the same expression intensity, but they were differently distributed at the membrane compartments with a remarkable decrease in both marker genes in ectopic endometrial lesions (Figure 3b,c) . A moderate staining of EGF and EGF-R could also be detected in stromal cells of eutopic endometrium but not in the ectopic samples.
E-cadherin
Most of the endometria of the not affected women showed a strong to moderate E-cadherin expression (Figure 4a) , only 20% revealed a weak reactivity to E-cadherin (Figure 5a ). The adhesion molecule E-cadherin was found along the complete lateral cell membranes of the glandular epithelium ( Figure  4a,b) .
The endometrium of patients with endometriosis showed a shift to a more moderate expression, in the same distribution pattern along the complete lateral membrane (Figures 4b, 5a) . No reaction could be stated in a small amount (8%) of eutopic biopsies of affected women (Figure 5a ). Immunostaining of E-cadherin in ectopic endometria was in general weak and in 52% of the samples not detectable (Figures 4c, 5a) . Of endometrial sections of normal cycling women, 61% exhibited a strong and 39% a moderate staining of α-catenin whereas only 52% of the samples of endometriosis patients in the surrounding stroma of the ectopic endometrial lesions (Figure 1c,d) .
were strong and 29% moderately stained. In the remaining biopsies only a low expression of α-catenin was found within EGF and EGF-R the glandular epithelium (Figure 5b) . In contrast to α-catenin, the β-catenin concentration differed Expression of EGF in the uterine epithelium of eutopic endometrium of patients with and without endometriosis was more distinctly between the eutopic endometrial tissues of patients with and without endometriosis. In the endometrium lesions. As shown for EGF-R in Figure 6 , there was also no variation in the expression intensity of all other marker genes of normal cycling women, staining for β-catenin was strong in 21% of the samples and in 61% a moderate immunofluoresinvestigated related to the different oestrogen concentrations during the proliferative phase. The progesterone serum concence was observed (Figures 4g, 5c ). Endometrial biopsies of patients with endometriosis showed a strong (20%) and centrations varied only moderately during this phase and were Ͻ1.0 ng/ml. For this reason a correlation with progesterone moderate (24%) or low (44%) expression of β-catenin (Figures  4h, 5c ). 12% were β-catenin immunonegative (Figure 5c ). serum concentrations was not performed. The α-catenin and β-catenin immunoreactivity differed clearly between eutopic and ectopic endometria. A strong Discussion expression of α-catenin could be shown only in 12% of the ectopic lesions, a moderate immunoreaction in 27%. Of ectopic The molecular mechanisms underlying the pathogenesis of endometriosis are far from being understood. Since most glands, 46% expressed α-catenin at a low intensity and in an inhomogeneous distribution pattern (Figure 4f ). In 15% of the of the observations described in the literature concerning different marker molecules characteristic for this disease are samples staining for α-catenin was negative (Figure 5b ).
Immunoreaction to β-catenin was mainly very weak in the contradictionary, it is difficult to draw a clear line about the cell biological processes involved. In this study we tried to glandular epithelium of the lesions and was completely missing in a third of all samples (Figures 4i, 5c ).
define if generation and persistence of endometriotic lesions are due to a more proliferative or more invasive character. For Correlation of differentiation markers to serum this reason we investigated marker molecules involved in oestrogen concentrations invasion and markers discussed for increased proliferation of endometria and endometriotic lesions within the same group of Since in our study the serum oestradiol concentrations demonstrated variations of 17-290 pg/ml, we tested whether patients. In our study, we found no differences in proliferation activity between eutopic endometria of patients with and these different concentrations influence the expression pattern of the differentiation markers. For this reason we divided the without endometriosis, but a remarkably reduced proliferative activity of the ectopic lesions was shown. These observations patients into three groups, based on the serum concentration of oestradiol (Ͻ30; 30-100; and ജ100 pg/ml) and correlated are in agreement with previously published studies (Jones et al., 1995) and seem quite reasonable because all lesions these concentrations of oestradiol with the expression intensity of EGF, EGF-R, E-cadherin, α-and β-catenin within the investigated have been very small in extent. The reduced proliferative activity is correlated with a reduction in EGF and three different tissue groups, endometria from normal cycling patients, from patients with endometriosis and ectopic EGF-R in the epithelial cells of the ectopic glands. Figure 5 . Variation of the expression of (a) E-cadherin, Figure 6 . Staining intensity of epidermal growth factor receptor (b) α-catenin, and (c) β-catenin in the epithelium of eutopic (EGF-R) in eutopic endometria of women without endometriosis endometria of normal cycling women (En n E-cad ϭ 25; n α-cat ϭ 23; (a), patients with endometriosis (b), and in endometriotic lesions n β-cat ϭ 28), endometria of patients with endometriosis (EnEMT (c) with regard to the corresponding oestradiol (E 2 ) concentration at n E-cad ϭ 24, n α-cat ϭ 20 , n β-cat ϭ 25) and in endometriotic biopsies the time of biopsy. (EMT n E-cad ϭ 21; n α-ca t ϭ 26; n β-cat ϭ 26). The numbers of biopsies showing no (-), weak (ϩ), moderate (ϩϩ) or strong (ϩϩϩ) immunohistochemical staining intensity are expressed as mRNA than endometriotic lesions. However, using immunopercentages.
histochemistry, no differences were found in the staining intensity of eutopic and ectopic endometria. We would postulate that this disease is less responsive to oestrogens by reduction EGF which acts through its receptor via paracrine or autocrine mechanisms is known to be regulated during the of the EGF-R and this may cause the reduction in proliferation of the ectopic glands. A further indication is that, although the menstrual cycle (Bonaccorsi et al., 1989; Troche et al., 1991) . In animal models, oestrogen is able to enhance the amount of serum concentrations of oestrogen differed among patients, no differences in proliferation activity could be observed. How-EGF-R (Mukku and Stancel, 1985) and EGF is able to replace the action of oestrogen in the mouse genital tract with respect ever, other growth factors which may compensate for EGF, e.g. IGF-I (Roy et al., 1999) or transforming growth factor α to growth and differentiation (Nelson et al., 1991) . Our observations of a reduction of EGF-R in endometriotic lesions, (TGFα) (Imai et al., 1995 , Niikura et al., 1996 , which have been shown to be expressed in human endometria and but not in eutopic endometria, is in agreement with a previous study (Huang and Yeh, 1994) . These authors showed that endometrial carcinoma, have not been investigated in this study. In conclusion, some proliferation probably responsible eutopic endometria have a higher relative abundance of EGF-R for persisting and slow growing of the lesions, seems to be that invasion of endometriotic lesions is influenced by the local environment is supported by the other experiments in needed. However, in our study there is no evidence for enhanced proliferative activity as a mechanism for pathogenesis which the invasive capacity of an endometriotic cell line could be enhanced by adding peritoneal fluid in a collagen invasion and progression of this disease.
The transmembrane cell adhesion protein E-cadherin is assay (Starzinski-Powitz et al., 1998) . In conclusion, our studies suggest that ectopic endometrium undergoes a dedifferentiation thought to be involved as tumour suppressor gene in carcinogenesis (Vleminckx et al., 1991; Birchmeier et al., 1995) . Loss process along the invasive pathway but shows no evidence for enhanced proliferation properties. of intercellular adhesion mediated by the cadherin/catenin complex plays a key role in the precondition for loss of cell polarity and the onset of cell invasion leading to metastasis
